SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000921895-18-003382
Filing Date
2018-12-26
Accepted
2018-12-26 16:27:16
Documents
2

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13G sc13g07422vbi_12262018.htm SC 13G 207519
2 JOINT FILING AGREEMENT ex991to13g07422vbi_12262018.htm EX-99.1 11082
  Complete submission text file 0000921895-18-003382.txt   220460
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Subject) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89195 | Film No.: 181252896
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104
Business Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice
Assistant Director 7